Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep 9;18(6):345-52.
doi: 10.1016/j.rpor.2013.08.002.

Clinical and technological transition in breast cancer

Philip Poortmans  1 , Hugo Marsiglia  2 , Manuel De Las Heras  3 , Manuel Algara  4
Affiliations
Review

Clinical and technological transition in breast cancer

Philip Poortmans et al. Rep Pract Oncol Radiother. .

Abstract

This article is a summary of the conference "Clinical and technological transition in breast cancer" that took place in the Congress of the Spanish Society of Radiation Oncology, placed in Vigo (Spain) on June 21, 2013. Hugo Marsiglia and Philip Poortmanns were the speakers, the first discussed about "Clinical and technological transition" and the second about "EORTC clinical trials and protocols".

Keywords: Breast cancer; Clinical trial; Radiotherapy; Technological.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Cumulative incidence of ipsilateral breast cancer recurrence according to age. Age (A) ≤40, (B) 41–50, (C) 51–60, and (D) ≥60 years. HR, hazard ratio; O, occurrences; N, number of patients at risk.
Fig. 2
Fig. 2
Cumulative incidence of moderate or severe fibrosis after 50 Gy whole breast irradiation, followed by no boost or a boost dose of 10 Gy, 16 Gy and 26 Gy, respectively. O, observed; N, number of patients at risk; CR, complete resection; IR, incomplete resection.
Fig. 3
Fig. 3
Local breast recurrence rate in three consecutive trials on breast conserving therapy from 1980 until 2012.
See this image and copyright information in PMC

References

    1. Lopez Guerra J.L., Isa N., Kim M.M., Bourgier C., Marsiglia H. New perspectives in radiation oncology: young radiation oncologist point of view and challenges. Rep Pract Oncol Radiother. 2012;17:251–254. - PMC - PubMed
    1. Kacprowska A., Jassem J. Partial breast irradiation techniques in early breast cancer. Rep Pract Oncol Radiother. 2011;16(6):213–220. - PMC - PubMed
    1. Livi L., Buonamici F.B., Simontacchi G. Accelerated partial breast irradiation with IMRT: new technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial. Int J Radiat Oncol Biol Phys. 2010;77:509–515. - PubMed
    1. Belkacemi Y., Bourgier C., Kramar A. SHARE: a french multicenter phase III trial comparing accelerated partial irradiation versus standard or hypofractionated whole breast irradiation in breast cancer patients at low risk of local recurrence. Clin Adv Hematol Oncol. 2013;11:76–83. - PubMed
    1. Lopez Guerra J.L., Isa N., Matute Hypofractionated helical tomotherapy using 2.5–2.6 Gy daily fractions for localized prostate cancer. Clin Transl Oncol. 2013;15:271–277. - PubMed

LinkOut - more resources